Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Pieris Pharmaceuticals (PIRS).
Pieris Pharmaceuticals, Inc. is implementing a 1-for-80 reverse stock split to boost its stock price above the $1.00 threshold, aiming to meet Nasdaq’s minimum bid price requirement. Set to take effect at market open on April 23, 2024, the move will automatically adjust shareholders’ stock quantities, ensuring no fractional shares remain by rounding up to whole shares. The action doesn’t require shareholder approval and is intended to help the company maintain its Nasdaq listing without changing shareholder equity, except for minimal adjustments due to the rounding of shares.
Learn more about PIRS stock on TipRanks’ Stock Analysis page.